Učitavanje...
A placebo-controlled Bayesian dose finding design based on continuous reassessment method with application to stroke research
Traditional dose-finding designs do not require assignment of patients to a control group. Motivated by SHRINC (Safety of Pioglitazone for hematoma resolution in intracerebral hemorrhage), we developed a placebo-controlled dose-finding study to identify the maximum tolerated dose for pioglitazone in...
Spremljeno u:
| Izdano u: | Contemp Clin Trials Commun |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2017
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5650116/ https://ncbi.nlm.nih.gov/pubmed/29062975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.conctc.2017.05.002 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|